n,n-dimethylarginine has been researched along with Chronic Insomnia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, XY; Luo, ZF; Wang, YS; Xiao, HB | 1 |
| Liang, L; Lu, X; Sun, ZL; Wang, YS; Xiao, HB | 1 |
2 other study(ies) available for n,n-dimethylarginine and Chronic Insomnia
| Article | Year |
|---|---|
SZSJ protects against insomnia by a decrease in ADMA level and an improvement in DDAH production in sleep-deprived rats.
Topics: Amidohydrolases; Animals; Arginine; Hypnotics and Sedatives; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Ziziphus | 2018 |
Procyanidin B2 from lotus seedpod regulate NO/ADMA/DDAH pathway to treat insomnia in rats.
Topics: Amidohydrolases; Animals; Arginine; Biflavonoids; Brain; Catechin; Lotus; Neurons; Nitric Oxide; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Seeds; Signal Transduction; Sleep; Sleep Initiation and Maintenance Disorders | 2019 |